Literature DB >> 20392996

Chemopreventive effects of honokiol on UVB-induced skin cancer development.

Shivani Chilampalli1, Xiaoying Zhang, Hesham Fahmy, Radhey S Kaushik, David Zeman, Michael B Hildreth, Chandradhar Dwivedi.   

Abstract

BACKGROUND: Skin cancer is the most prevalent of all cancer types and its incidence is expected to increase substantially. Chemoprevention involves the administration of chemical agents to prevent initiation, promotion and/or progression that occurs during neoplastic development. Honokiol, a plant lignan isolated from bark and seed cones of Magnolia officinalis, has been shown to have chemopreventive effects on chemically induced skin cancer development. AIM: The objective of this investigation was to study the chemopreventive effects of honokiol on UVB-induced skin tumor development in SKH-1 mice, a model relevant to humans, and to elucidate the possible role of apoptotic proteins involved in the prevention of skin tumor development.
MATERIALS AND METHODS: Female SKH-1 mice were divided into two groups. Group 1 received acetone (0.2 ml, topical) and Group 2 received honokiol (30 microg in 0.2 ml acetone, topical) one hour before UVB treatment. Tumor initiation and promotion were carried out by UVB radiation (30 mJ/cm(2)/day), 5 days a week for 30 weeks. Tumor counts and mouse weights were taken weekly.
RESULTS: The honokiol-pretreated group exhibited a 45% reduction in tumor multiplicity as compared to the control group. Mechanistic studies showed the possible involvement of caspase-3, caspase-8, caspase-9, poly (ADP-ribose) polymerase (PARP) and p53 activation (p<0.05) leading to the induction of DNA fragmentation and apoptosis.
CONCLUSION: Pretreatment with honokiol, at concentrations in micrograms per application compared with milligram applications of other potential chemopreventive agents, prevents UVB-induced skin cancer development, possibly by activating proapoptotic proteins through both intrinsic and extrinsic pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392996

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  25 in total

Review 1.  Phytochemicals for the Prevention of Photocarcinogenesis.

Authors:  Mary K Montes de Oca; Ross L Pearlman; Sarah F McClees; Rebecca Strickland; Farrukh Afaq
Journal:  Photochem Photobiol       Date:  2017-03-14       Impact factor: 3.421

2.  Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.

Authors:  A S Prakasha Gowda; Zucai Suo; Thomas E Spratt
Journal:  Chem Res Toxicol       Date:  2017-01-19       Impact factor: 3.739

Review 3.  Use of Polyphenolic Compounds in Dermatologic Oncology.

Authors:  Adilson Costa; Michael Yi Bonner; Jack L Arbiser
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

Review 4.  Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants.

Authors:  Anuradha Sehrawat; Ruchi Roy; Subrata K Pore; Eun-Ryeong Hahm; Suman K Samanta; Krishna B Singh; Su-Hyeong Kim; Kamayani Singh; Shivendra V Singh
Journal:  Semin Cancer Biol       Date:  2016-11-17       Impact factor: 15.707

Review 5.  Natural agents: cellular and molecular mechanisms of photoprotection.

Authors:  Farrukh Afaq
Journal:  Arch Biochem Biophys       Date:  2010-12-11       Impact factor: 4.013

6.  Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.

Authors:  Jiří Pospíšil; Daniela Konrádová; Miroslav Strnad
Journal:  Prog Chem Org Nat Prod       Date:  2021

Review 7.  Novel investigational drugs for basal cell carcinoma.

Authors:  Po-Lin So; Jean Y Tang; Ervin H Epstein
Journal:  Expert Opin Investig Drugs       Date:  2010-09       Impact factor: 6.206

8.  c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.

Authors:  Eun-Ryeong Hahm; Krishna Beer Singh; Shivendra V Singh
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

Review 9.  Honokiol: a novel natural agent for cancer prevention and therapy.

Authors:  S Arora; S Singh; G A Piazza; C M Contreras; J Panyam; A P Singh
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

10.  Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer.

Authors:  Yusuf A Haggag; Rowida R Ibrahim; Amin A Hafiz
Journal:  Int J Nanomedicine       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.